Shop Research Compounds
Home / Shop / hgh-somatropin
hgh-somatropin research product by Crystal Peptides
Muscle & Recovery

hgh-somatropin

10×15 IU

Recombinant human growth hormone reference compound for endocrine and growth-signaling research.

€185,00
Third-party testedCOA availableEU shippingResearch only
For in-vitro laboratory research only. Not for human or veterinary use.This information is provided for scientific and educational product context only. It does not describe or recommend human use, veterinary use, diagnosis, treatment, prevention, dosage, administration, or clinical application.
Research intelligence

Research context for HGH / Somatropin

This information is provided for scientific and educational product context only. It does not describe or recommend human use, veterinary use, diagnosis, treatment, prevention, dosage, administration, or clinical application.

Product research overview

Somatropin is recombinant human growth hormone. It has an established approved-drug context in regulated pharmaceutical products, while the material listed here is strictly research reference material and is not offered for human use.

MaterialRecombinant peptide hormone
Primary areaGH receptor and IGF-1 axis
EvidenceApproved-drug reference plus mechanistic research
CatalogMuscle & Recovery

Mechanism & pathway context

  • Growth hormone binds the growth hormone receptor and engages receptor-associated signaling, prominently JAK2/STAT pathways.
  • The broader somatotroph axis includes endocrine feedback and IGF-1-mediated signaling. Approved labels apply only to their specific regulated products.

GH receptor signaling

Ligand-receptor activation and downstream JAK/STAT events.

IGF-1 axis

Endocrine and local signaling relationships.

Growth biology

Cell differentiation and tissue-growth models.

Metabolic signaling

Experimental substrate and energy-regulation endpoints.

What researchers study

  • Growth hormone receptor binding and activation
  • JAK2 and STAT5 phosphorylation
  • IGF-1 feedback and gene expression
  • Endocrine and metabolic model endpoints

Current evidence snapshot

Evidence areaResearch contextStrengthNotes
Pharmaceutical identityFDA-approved somatropin productsEstablished reference contextApproval does not transfer to this storefront material.
Receptor mechanismCell and animal researchEstablished reference contextGHR/JAK2/STAT signaling is well characterized.
This productResearch-reference storefrontLimitedNo clinical equivalence or approved-product claim is made.

Limitations & safety boundaries

  • Somatropin exists as an approved medicine in regulated contexts, but this storefront material is not presented as an approved pharmaceutical.
  • Evidence may be limited to cell, tissue, or animal models and may not translate to humans.
  • No dosing, administration, preparation, or clinical guidance is provided.
  • Researchers and buyers are responsible for institutional requirements and applicable local laws.

For in-vitro laboratory research only. Not for human or veterinary use.